Could a new drug help the body recover after cardiac arrest?
NCT ID NCT07468292
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a drug called GC7 in 20 people who have had a cardiac arrest and been revived. The goal is to see if GC7 can reduce cell damage caused by the sudden return of blood and oxygen. Researchers will measure stress levels in blood cells and look for signs of improved recovery.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARDIAC ARREST (CA) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CHU de Nice - Hôpital PASTEUR 2
Nice, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Blood test may forecast brain recovery after cardiac arrest
- Can a High-Tech CPR bundle boost heart restart rates?
- A simple bedside test may predict brain damage after cardiac arrest
- Can a neck patch spot a heartbeat faster than a Doctor's fingers?
- Which hand position saves tiny lives? study pits four infant CPR techniques Head-to-Head
- Updated cardiac arrest guidelines may boost survival, study hints